FDA says Cerebral Health makes unapproved claims
This article was originally published in The Tan Sheet
Executive SummaryCerebral Health's marketing claims that Alzenia Anti-Aging Brain Formula, Memeron Memory Enhancer, Neurotine Amino Acid Brain Fuel, Synaptine Nootropic and Cognitive Enhancer, Synaptine Blue Brain Health Supplement and Synaptine Elite Maximum Strength Nootropic prevent or ease symptoms of Alzheimer's disease, Parkinson's disease, strokes, Down's syndrome and other mental ailments render the products unapproved new drugs. In a Jan. 7 warning letter to the Jupiter, Fla., firm, FDA says the products' ingredients are not generally recognized as safe and effective for the mentioned uses
You may also be interested in...
Last week, the Commission revealed that three more notified bodies had been designated; but their listings had not been made official. Now we learn that one of the three is in the Netherlands as the first listing takes place.